Global Principles on Incentivizing Antibiotic R&D

  18 February 2021

The COVID-19 pandemic has made it very clear that the
world needs to be better prepared for global threats posed
by infectious diseases. Antimicrobial resistance (AMR), if left
unchecked, risks undermining the achievements of modern
medicine and taking us back to a time where a simple cut
could become lethal.

Now, more than ever, we need to accelerate the creation of
a vibrant and sustainable innovation ecosystem to support
R&D for new antibiotics and other antimicrobials addressing
pathogens prioritized by leading public health bodies.
We call on governments to deliver new economic incentives,
pragmatic antibiotic value assessments, and reimbursement
reforms to enable access, that are needed to meet the needs
of patients of today and tomorrow.

Further reading: IFPMA
Author(s): IFPMA
Smart Innovations  
Back

OUR UNDERWRITERS

Unrestricted financial support by:

LifeArc

Antimicrobial Resistance Fighter Coalition

Bangalore Bioinnovation Centre

INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS





Global Ambassador Network

Welcome at the AMR Insights Ambassador Network!

The AMR Insights Ambassador Network is a growing, distinctive group of professionals who stand out for their commitment, willingness to cooperate and open attitude to combat Antimicrobial resistance (AMR).

More information and free-of-charge registration
What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!